Examkin

Soru

Zorluk: ZorGynecologic Infections

A 45-year-old woman is evaluated in the clinic for persistent vaginal symptoms. Three weeks ago, she presented with a profuse, malodorous, yellowish-green vaginal discharge and severe vulvar pruritus. At that time, speculum examination revealed punctate macular hemorrhages on the ectocervix. A saline wet mount confirmed the presence of motile, flagellated organisms with multiple polymorphonuclear leukocytes. The vaginal pH was 6.56.5. She was prescribed a 77-day course of oral metronidazole, 500500 mg twice daily. During today's visit, she reports that her symptoms briefly improved but completely returned five days ago. The patient confirms strict adherence to the prescribed medication regimen and states she has abstained from all sexual contact since before her initial visit. Her medical history is otherwise unremarkable. Repeat saline microscopy of the discharge today demonstrates the same motile organisms seen previously. Which of the following is the most appropriate next step in management?

  1. Initiate a 7-day course of oral tinidazoleCevap
  2. B
    Prescribe a 5-day course of intravaginal metronidazole gel
  3. C
    Administer a single 2-gram dose of oral metronidazole
  4. D
    Transition to intramuscular ceftriaxone and oral azithromycin
  5. E
    Advise symptomatic relief with vaginal boric acid suppositories

Cevap

Initiate a 7-day course of oral tinidazole
The correct answer is to initiate a 7-day course of high-dose oral tinidazole. The patient has refractory trichomoniasis. She was treated with the standard initial regimen for women (7 days of oral metronidazole 500 mg twice daily). Because she strictly adhered to the regimen and completely abstained from sexual intercourse, reinfection is effectively excluded, pointing to a nitroimidazole-resistant strain. The CDC recommends treating such documented treatment failures with an escalated regimen of a 7-day course of either oral metronidazole 2 g daily or oral tinidazole 2 g daily.

Adım Adım Çözüm

1
Identify the underlying organism from the initial presentation and microscopic findings.
Trichomonas vaginalis (motile, flagellated protozoa, strawberry cervix, pH > 4.5).
Establishes the baseline diagnosis required to evaluate the clinical course.
2
Evaluate the patient's response to the initial standard therapy (77 days of oral metronidazole).
Treatment failure confirmed by recurrent symptoms and a positive repeat wet mount.
Determines that the initial pharmacotherapy was unsuccessful.
3
Determine the cause of treatment failure based on the patient's history.
Patient was fully compliant and completely abstinent, ruling out reinfection.
Differentiates true antimicrobial resistance from reinfection (which would just require repeating the initial dose and treating the partner).
4
Select the appropriate second-line pharmacotherapy for metronidazole-resistant trichomoniasis.
High-dose oral tinidazole (22 g daily for 77 days) or high-dose oral metronidazole (22 g daily for 77 days).
Standard guideline-concordant care for confirmed refractory trichomoniasis to overcome baseline nitroimidazole resistance.

Anahtar Kavram

Management of treatment-resistant Trichomonas vaginalis infection requires excluding reinfection and escalating to high-dose, 7-day systemic nitroimidazole therapy.
Tahmini Süre:1m 30s
Bu soruyu puanla

Konular

Gynecologic Infections

Bu konudan daha fazla soru